Cargando…

Survie et facteurs pronostiques du cancer bronchique non à petites cellules chez le sujet jeune au centre tunisien

INTRODUCTION: Non-small cell lung cancer (NSCLC) is a public health problem that usually affects the elderly. Currently and for some years now, this disease is increasingly affecting the young population. The purpose of this study was to analyze the features of NSCLC in young subjects and to assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Joobeur, Samah, Ben Saad, Ahmed, Migaou, Asma, Fahem, Nesrine, Mhamed, Saousen Cheikh, Rouatbi, Naceur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170746/
https://www.ncbi.nlm.nih.gov/pubmed/32341740
http://dx.doi.org/10.11604/pamj.2020.35.19.21100
_version_ 1783523940136648704
author Joobeur, Samah
Ben Saad, Ahmed
Migaou, Asma
Fahem, Nesrine
Mhamed, Saousen Cheikh
Rouatbi, Naceur
author_facet Joobeur, Samah
Ben Saad, Ahmed
Migaou, Asma
Fahem, Nesrine
Mhamed, Saousen Cheikh
Rouatbi, Naceur
author_sort Joobeur, Samah
collection PubMed
description INTRODUCTION: Non-small cell lung cancer (NSCLC) is a public health problem that usually affects the elderly. Currently and for some years now, this disease is increasingly affecting the young population. The purpose of this study was to analyze the features of NSCLC in young subjects and to assess survival as well as the various prognostic factors. METHODS: We conducted a retrospective study of all patients under the age of 50 years treated in the Department of Pneumology at the Fattouma Bourguiba University Hospital, Monastir for NSCLC. Survival and prognostic factors have been analyzed according to Kaplan Meier method. RESULTS: The average age of patients was 43.8 ± 5.29 years. The most common histological type was lung adenocarcinoma (66.1%). NSCLC was discovered at an advanced or metastatic stage in 79.7% of cases. The median overall survival was 8 ± 0.72 months. Univariate analysis showed that survival was significantly influenced by patients’ general status, assessed according to the “Performance Status (PS)” index of the World Health Organization on admission, tumor stage and CRP concentrations. Multivariate analysis was performed, which enabled us to use PS index ≥ 2 and high CRP concentrations as factors of poor prognosis. CONCLUSION: Despite the therapeutic progress, prognosis in young subjects with NSCLC is poor. Early diagnosis and management can improve survival in these patients.
format Online
Article
Text
id pubmed-7170746
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The African Field Epidemiology Network
record_format MEDLINE/PubMed
spelling pubmed-71707462020-04-27 Survie et facteurs pronostiques du cancer bronchique non à petites cellules chez le sujet jeune au centre tunisien Joobeur, Samah Ben Saad, Ahmed Migaou, Asma Fahem, Nesrine Mhamed, Saousen Cheikh Rouatbi, Naceur Pan Afr Med J Research INTRODUCTION: Non-small cell lung cancer (NSCLC) is a public health problem that usually affects the elderly. Currently and for some years now, this disease is increasingly affecting the young population. The purpose of this study was to analyze the features of NSCLC in young subjects and to assess survival as well as the various prognostic factors. METHODS: We conducted a retrospective study of all patients under the age of 50 years treated in the Department of Pneumology at the Fattouma Bourguiba University Hospital, Monastir for NSCLC. Survival and prognostic factors have been analyzed according to Kaplan Meier method. RESULTS: The average age of patients was 43.8 ± 5.29 years. The most common histological type was lung adenocarcinoma (66.1%). NSCLC was discovered at an advanced or metastatic stage in 79.7% of cases. The median overall survival was 8 ± 0.72 months. Univariate analysis showed that survival was significantly influenced by patients’ general status, assessed according to the “Performance Status (PS)” index of the World Health Organization on admission, tumor stage and CRP concentrations. Multivariate analysis was performed, which enabled us to use PS index ≥ 2 and high CRP concentrations as factors of poor prognosis. CONCLUSION: Despite the therapeutic progress, prognosis in young subjects with NSCLC is poor. Early diagnosis and management can improve survival in these patients. The African Field Epidemiology Network 2020-01-23 /pmc/articles/PMC7170746/ /pubmed/32341740 http://dx.doi.org/10.11604/pamj.2020.35.19.21100 Text en © Samah Joobeur et al. http://creativecommons.org/licenses/by/2.0/ The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Joobeur, Samah
Ben Saad, Ahmed
Migaou, Asma
Fahem, Nesrine
Mhamed, Saousen Cheikh
Rouatbi, Naceur
Survie et facteurs pronostiques du cancer bronchique non à petites cellules chez le sujet jeune au centre tunisien
title Survie et facteurs pronostiques du cancer bronchique non à petites cellules chez le sujet jeune au centre tunisien
title_full Survie et facteurs pronostiques du cancer bronchique non à petites cellules chez le sujet jeune au centre tunisien
title_fullStr Survie et facteurs pronostiques du cancer bronchique non à petites cellules chez le sujet jeune au centre tunisien
title_full_unstemmed Survie et facteurs pronostiques du cancer bronchique non à petites cellules chez le sujet jeune au centre tunisien
title_short Survie et facteurs pronostiques du cancer bronchique non à petites cellules chez le sujet jeune au centre tunisien
title_sort survie et facteurs pronostiques du cancer bronchique non à petites cellules chez le sujet jeune au centre tunisien
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170746/
https://www.ncbi.nlm.nih.gov/pubmed/32341740
http://dx.doi.org/10.11604/pamj.2020.35.19.21100
work_keys_str_mv AT joobeursamah survieetfacteurspronostiquesducancerbronchiquenonapetitescelluleschezlesujetjeuneaucentretunisien
AT bensaadahmed survieetfacteurspronostiquesducancerbronchiquenonapetitescelluleschezlesujetjeuneaucentretunisien
AT migaouasma survieetfacteurspronostiquesducancerbronchiquenonapetitescelluleschezlesujetjeuneaucentretunisien
AT fahemnesrine survieetfacteurspronostiquesducancerbronchiquenonapetitescelluleschezlesujetjeuneaucentretunisien
AT mhamedsaousencheikh survieetfacteurspronostiquesducancerbronchiquenonapetitescelluleschezlesujetjeuneaucentretunisien
AT rouatbinaceur survieetfacteurspronostiquesducancerbronchiquenonapetitescelluleschezlesujetjeuneaucentretunisien